Applied DNA Sciences (NASDAQ:APDN) Issues Earnings Results, Misses Estimates By $12.35 EPS

Applied DNA Sciences (NASDAQ:APDN) posted its earnings results on Thursday. The technology company reported ($15.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.00) by ($12.35), Zacks reports. The business had revenue of $0.98 million for the quarter, compared to analyst estimates of $1.19 million. Applied DNA Sciences had a negative net margin of 228.12% and a negative return on equity of 101.57%.

Applied DNA Sciences Stock Performance

Shares of Applied DNA Sciences stock opened at $0.67 on Friday. The firm has a 50-day simple moving average of $1.29 and a two-hundred day simple moving average of $6.27. The company has a market cap of $739,680.00, a P/E ratio of -0.12 and a beta of 0.41. Applied DNA Sciences has a fifty-two week low of $0.63 and a fifty-two week high of $177.00.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of Applied DNA Sciences in a research report on Monday, March 17th. They issued a “sell” rating for the company.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.